Sulfanilamide Prices

Sulfanilamide Price Trend, Index and Forecast

Track the latest insights on sulfanilamide price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.

Sulfanilamide Prices Outlook Q1 2026

• USA: USD 32508/MT
• China: USD 19993/MT
• Germany: USD 31103/MT
• South Korea: USD 35075/MT
• Brazil: USD 32924/MT

Sulfanilamide Price Chart

Get real-time access to monthly/quarterly/yearly prices Request Sample

During the first quarter of 2026, the sulfanilamide prices in the USA reached 32508 USD/MT in March. Prices moved upward as domestic demand from pharmaceutical and specialty chemical buyers improved, while buyers maintained steady procurement to avoid supply gaps. Feedstock availability remained manageable, but firm production costs supported higher offers. Import competition was limited by freight costs and cautious supplier allocations, which helped domestic sellers protect margins.

During the first quarter of 2026, the sulfanilamide prices in China reached 19993 USD/MT in March. Prices declined as domestic supply remained adequate and downstream buyers avoided aggressive stock building. Pharmaceutical intermediate demand was steady but not strong enough to absorb available inventories at higher offer levels. Producers faced pressure from slower export inquiries and competitive pricing from regional suppliers. Feedstock costs offered limited support, while sellers reduced offers to encourage fresh bookings.

During the first quarter of 2026, the sulfanilamide prices in Germany reached 31103 USD/MT in March. Prices softened as downstream buyers adopted careful procurement strategies amid stable but restrained pharmaceutical and specialty chemical demand. Imported material availability improved, which reduced pressure on local supply channels. Sellers faced weaker spot buying and had limited room to maintain elevated offers. Energy and operating costs remained relevant, but they were not strong enough to offset the drag from slower consumption.

During the first quarter of 2026, the sulfanilamide prices in South Korea reached 35075 USD/MT in March. Prices declined as buyers reduced fresh procurement and relied on earlier inventories. Demand from pharmaceutical intermediate and chemical synthesis users stayed moderate, but buying interest weakened as customers expected further price softness. Import availability from Asian suppliers remained sufficient, which increased competition and weighed on domestic offers. Producers lowered quotations to secure orders and maintain plant utilization.

During the first quarter of 2026, the sulfanilamide prices in Brazil reached 32924 USD/MT in March. Prices increased as import dependent supply channels faced firmer replacement costs and steady demand from pharmaceutical and specialty chemical users. Local inventories were not excessive, which allowed sellers to hold stronger offers. Currency related procurement risks also encouraged buyers to secure material before further cost changes. Import lead times and cautious supplier allocations supported upward pricing.

Sulfanilamide Prices Outlook Q4 2025

• USA: USD 32113/MT
• China: USD 20445/MT
• Germany: USD 32101/MT
• South Korea: USD 35868/MT
• Brazil: USD 32487/MT

During the fourth quarter of 2025, the sulfanilamide prices in the USA reached 32113 USD/MT in December. The market reflected a firm upward trajectory supported by stable pharmaceutical sector procurement and consistent demand from specialty chemical formulators. Domestic production costs remained elevated due to higher feedstock sourcing expenses and firm energy tariffs, which reinforced the bullish tone. Inventory restocking ahead of year-end contracts also sustained transactional activity.

During the fourth quarter of 2025, the sulfanilamide prices in China reached 20445 USD/MT in December. Softened export orders and cautious procurement from producers of downstream pharmaceutical intermediates put downward pressure on the market. Negotiations were hampered by the abundance of home supply, as manufacturers maintained very steady pricing in the face of modest local demand. Price modifications were also influenced by competitive export pricing strategies, particularly in reaction to a decline in regional buying sentiment.

During the fourth quarter of 2025, the sulfanilamide prices in Germany reached 32101 USD/MT in December. The market displayed a declining trend influenced by moderated demand from pharmaceutical manufacturers and distributors. Buyers adopted conservative purchasing strategies, aligning procurement with immediate production requirements rather than forward stocking. Energy cost stabilization provided limited support, but overall production expenses remained manageable, allowing suppliers to offer competitive rates.

During the fourth quarter of 2025, the sulfanilamide prices in South Korea reached 35868 USD/MT in December. Prices trended downward amid moderated export activity and cautious downstream purchasing behavior. Although domestic pharmaceutical demand remained stable, it was insufficient to counteract slower overseas inquiries. Producers maintained steady output levels, resulting in adequate inventories across distribution channels.

During the fourth quarter of 2025, the sulfanilamide prices in Brazil reached 32487 USD/MT in December. The market reflected a downward movement influenced by tempered demand from pharmaceutical formulators and distributors. Import availability improved compared to earlier periods, easing supply concerns and increasing competition among suppliers. Currency stability limited extreme volatility, yet cautious buying behavior persisted amid balanced inventory levels.

Sulfanilamide Prices Outlook Q3 2025

• USA: USD 31244/MT
• China: USD 20886/MT
• Germany: USD 33060/MT
• South Korea: USD 36563/MT
• Brazil: USD 33255/MT

During the third quarter of 2025, the sulfanilamide prices in the USA reached 31244 USD/MT in September. This price reflected an increase compared to the previous quarter. The uptick was mainly driven by rising demand in the pharmaceutical and agrochemical sectors, where sulfanilamide is used as a precursor in the production of antibiotics and pesticides. Prices were also increased due to supply-side factors, including higher raw material costs and increased production expenses due to inflationary pressures on labor and energy costs.

During the third quarter of 2025, the sulfanilamide prices in China reached 20886 USD/MT in September. The increase from Q2 prices was attributed to a tightening supply of sulfanilamide in the domestic market. Raw material shortages, exacerbated by disruptions in the global supply chain, led to higher production costs. Additionally, China’s domestic demand for sulfanilamide in the pharmaceutical industry increased.

During the third quarter of 2025, the sulfanilamide prices in Germany reached 33060 USD/MT in September. Prices fell due to a slowdown in pharmaceutical production as several large-scale contracts were delayed. Demand from the agrochemical sector remained steady, but a reduction in production volumes for other industries, including specialty chemicals, created an excess of sulfanilamide in the market, putting downward pressure on prices. The ongoing challenges in energy costs also had a mixed effect on manufacturing costs, with some companies adjusting production methods to maintain profitability without raising prices.

During the third quarter of 2025, the sulfanilamide prices in South Korea reached 36563 USD/MT in September. The decline was mainly due to a shift in demand dynamics within the domestic market. South Korean manufacturers faced a significant drop in orders from key export markets, primarily due to increasing competition from low-cost suppliers in Southeast Asia. Furthermore, raw material costs remained relatively stable, and there was little pressure from domestic production costs.

During the third quarter of 2025, the sulfanilamide prices in Brazil reached 33255 USD/MT in September. A key driver of price increase was the rising demand for sulfanilamide in the Brazilian pharmaceutical market, which is experiencing growth due to the country’s expanding healthcare sector. The domestic production of sulfanilamide was impacted by logistical challenges, including port congestion and transportation delays, which raised overall shipping costs.

Sulfanilamide Prices Outlook Q2 2025

• USA: USD 30780/MT
• China: USD 20435/MT
• Germany: USD 33460/MT
• South Korea: USD 37500/MT
• Brazil: USD 32660/MT

During the second quarter of 2025, sulfanilamide prices in the USA reached 30780 USD/MT in June. In the USA, sulfanilamide prices stayed steady, supported by consistent pharmaceutical demand and adequate domestic availability. Imports complemented supply chains, though stable raw material costs limited any strong upward momentum. Buyers adopted cautious procurement, aligning purchases with immediate needs. The absence of major disruptions in logistics or feedstock ensured smooth market flow. Overall, the US sulfanilamide market reflected stability, with balanced supply-demand dynamics and restrained market activity preventing significant price fluctuations during the quarter.

During the second quarter of 2025, sulfanilamide prices in China reached 20435 USD/MT in June. In China, sulfanilamide prices remained stable, supported by steady pharmaceutical sector consumption and strong domestic production capacity. Export activity was moderate, with regional demand taking precedence over international shipments. Raw material costs were steady, keeping production economics favorable and prices within a narrow range. Buyers followed cautious procurement patterns, meeting short-term requirements. With no major supply disruptions, the Chinese sulfanilamide market-maintained balance, marked by sufficient availability and consistent consumption, resulting in stable pricing throughout the quarter.

During the second quarter of 2025, the sulfanilamide prices in Germany reached 33460 USD/MT in June. In Germany, sulfanilamide prices reflected a stable to slightly soft tone, shaped by cautious buying trends from pharmaceutical and veterinary applications. Domestic supply was adequate, while imports ensured smooth availability across the market. Stable raw material values kept production costs in check, preventing significant fluctuations. Buyers avoided aggressive stockpiling, instead meeting immediate requirements. With balanced fundamentals and consistent but moderate demand, the German sulfanilamide market stayed steady, showing little volatility during the quarter while maintaining predictable trading patterns.

During the second quarter of 2025, the sulfanilamide prices in South Korea reached 37500 USD/MT in June. In South Korea, sulfanilamide prices remained stable, driven by steady demand from pharmaceutical intermediates and controlled supply conditions. Domestic producers maintained balanced operating rates, while imports supplemented availability when needed. Raw material costs stayed firm, supporting manageable production economics without causing major price swings. Buyers adopted conservative procurement strategies, aligning purchases with short-term needs. With no significant disruptions in supply chains or demand surges, the South Korean sulfanilamide market reflected steady fundamentals, ensuring stable pricing throughout the quarter.

During the second quarter of 2025, the sulfanilamide prices in Brazil reached 32660 USD/MT in June. In Brazil, sulfanilamide prices remained relatively stable, influenced by steady pharmaceutical sector demand and reliance on imports to meet domestic requirements. International market trends played a key role, though balanced global supply helped avoid sharp fluctuations. Buyers were cautious, focusing on short-term procurement and avoiding large-scale inventory buildup. Stable raw material values supported predictable pricing, while logistics remained smooth. Overall, the Brazilian sulfanilamide market displayed steady fundamentals, with adequate supply and moderate demand keeping prices within a stable range.

Regional Coverage

The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing sulfanilamide prices.

Europe Sulfanilamide Price Trend

Q1 2026:

The sulfanilamide price index in Europe moved lower as restrained downstream demand and improved import availability pressured regional offers. Germany reflected this softer tone, with buyers maintaining cautious procurement and avoiding larger commitments. Pharmaceutical intermediate demand remained stable, but not strong enough to support firmer pricing. Distributors focused on stock correction after earlier purchases, which reduced spot buying. Energy and operating costs remained present, but sellers found it difficult to pass through higher costs in a weak demand environment. Competitive imports from Asian suppliers also limited pricing power.

Q4 2025:

During the fourth quarter of 2025, the sulfanilamide price index in Europe reflected a generally softening trend influenced by moderate pharmaceutical demand and stable import flows. Procurement activity from drug manufacturers remained aligned with immediate production schedules, limiting bulk purchasing and forward stocking. Ample arrivals from Asian suppliers enhanced product availability across major European ports, intensifying competition among distributors. Although energy markets remained comparatively stable, preventing abrupt production cost spikes, manufacturers faced limited margin expansion opportunities due to cautious buyer sentiment.

Q3 2025:

Europe showed moderate fluctuations. Prices in key market like Germany experienced slight downward pressure due to a decrease in industrial demand, particularly from the agrochemical sector. Supply constraints from global markets, combined with high energy prices, caused production costs to rise. However, stable demand in the pharmaceutical sector helped mitigate larger price declines, leading to a relatively less bearish market.

Q2 2025:

As per the sulfanilamide price index, European sulfanilamide prices remained stable with a slightly soft tone due to cautious demand from pharmaceutical and veterinary applications. Producers maintained balanced operating rates to avoid inventory overhangs, while steady raw material costs kept production economics in check. Import flows were sufficient, ensuring smooth availability across the region. Buyers remained selective in procurement, focusing on immediate requirements rather than bulk purchases. Overall, the European sulfanilamide market reflected steady fundamentals, characterized by balanced supply and restrained demand activity.

This analysis can be extended to include detailed sulfanilamide price information for a comprehensive list of countries.

North America Sulfanilamide Price Trend

Q1 2026:

The sulfanilamide price index in North America increased, supported by firmer procurement from pharmaceutical and specialty chemical buyers. The USA market showed upward movement as steady downstream consumption met limited spot availability. Sellers gained support from controlled inventories and firmer replacement costs. Import competition remained present, but freight and sourcing risks reduced its pressure on domestic offers. Buyers continued to purchase carefully, yet they showed stronger willingness to secure volumes due to supply concerns. Production costs also helped maintain firm market sentiment.

Q4 2025:

During the fourth quarter of 2025, the sulfanilamide price index in North America demonstrated an upward movement, supported by steady domestic consumption but tempered by adequate supply. Pharmaceutical manufacturers maintained consistent operating rates, underpinning baseline demand across the region. At the same time, reliable domestic production and regular import inflows ensured comfortable supply conditions. Logistics networks operated efficiently, reducing freight-related uncertainties and limiting abrupt cost variations.

Q3 2025:

In North America, the sulfanilamide price index for Q3 2025 saw steady growth, particularly in the USA. The main drivers of this increase were rising demand from both the pharmaceutical and agrochemical industries. Logistics challenges, including higher shipping costs and port congestion, further escalated prices. The strong USD also contributed to higher import costs for certain raw materials. While domestic production remained stable, external factors such as global supply chain issues, including delays in raw material shipments, helped push prices higher in Q3.

Q2 2025:

In North America, sulfanilamide prices stayed relatively stable, shaped by consistent demand from pharmaceutical manufacturing and controlled supply conditions. Domestic production was sufficient to meet market requirements, while imports supplemented availability without major disruptions. Buyers were cautious in procurement, with no rush toward stockpiling given predictable cost structures. Raw material stability ensured smooth production flows, keeping the market from sharp fluctuations. Overall, sulfanilamide prices in North America displayed steady fundamentals, supported by adequate supply and moderate but consistent consumption.

Specific data on sulfanilamide prices within the United States and Canada can also be provided.

Middle East and Africa Sulfanilamide Price Trend

Q1 2026:

The study examines the Middle East and Africa's sulfanilamide pricing trends and chart, taking into account variables that specifically affect market prices, such as regional industrial expansion, the availability of natural resources, and geopolitical conflicts.

Q4 2025:

As per sulfanilamide price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.

Q3 2025:

The report explores the sulfanilamide pricing trends and sulfanilamide price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on sulfanilamide prices for countries can also be provided.

Asia Pacific Sulfanilamide Price Trend

Q1 2026:

In the Asia Pacific, sulfanilamide prices moved lower in several key markets, led by weaker sentiment in China and South Korea. Supply remained sufficient, and producers faced pressure from slow export inquiries and cautious downstream buying. Pharmaceutical intermediate users purchased mainly for immediate needs, which reduced the scope for price recovery. Competitive offers from regional suppliers weighed on negotiations. Feedstock cost support was limited, and sellers adjusted quotations to maintain order flow. South Korea followed the same softer direction as buyers relied on existing stocks.

Q4 2025:

Across the Asia Pacific, the fourth quarter witnessed softening sulfanilamide prices amid balanced supply and cautious downstream demand. Pharmaceutical and specialty chemical manufacturers maintained stable production schedules but avoided aggressive inventory expansion. Export-oriented suppliers adjusted pricing structures to remain competitive in global markets, particularly amid moderated overseas inquiries. Feedstock conditions remained largely stable, limiting upward cost pressures and allowing flexibility in negotiations. Efficient logistics and improved port throughput facilitated consistent product movement, reinforcing comfortable regional availability.

Q3 2025:

In the Asia Pacific, sulfanilamide prices increased moderately, especially in China, due to supply-side constraints and increasing domestic demand. Production disruptions in key manufacturing hubs, coupled with increasing labor and energy costs, led to price hikes in several countries. Additionally, export demand for sulfanilamide from Southeast Asian countries contributed to the price rise. Despite these increases, demand for sulfanilamide in other markets remained stable, keeping the regional market somewhat balanced. The continued expansion of the pharmaceutical sector in India and China further fueled demand in the region.

Q2 2025:

In the Asia-Pacific region, sulfanilamide prices demonstrated stability supported by consistent demand from pharmaceutical intermediates. China and India, being major producers, kept supply chains well-balanced, though competitive pricing restrained significant upward trends. Feedstock costs remained steady, ensuring manageable production economics. Export opportunities were moderate, with regional consumption acting as the key driver. End-use industries adopted cautious procurement strategies, aligning purchases with near-term needs. Overall, APAC’s sulfanilamide market reflected balanced fundamentals, characterized by stable costs, steady demand, and well-maintained supply.

This analysis can be further extended to include detailed sulfanilamide prices for a comprehensive list of countries within the region.

Latin America Sulfanilamide Price Trend

Q1 2026:

In Latin America, sulfanilamide prices strengthened as Brazil saw firmer import replacement costs and steady downstream demand. Regional buyers remained dependent on overseas suppliers, which made freight, currency, and supplier allocation trends important for pricing. Local inventories were not excessive, allowing sellers to hold stronger offers. Demand from pharmaceutical and specialty chemical applications remained consistent, supporting market confidence. Buyers were cautious but still secured material to prevent supply delays.

Q4 2025:

In Latin America, sulfanilamide prices during the fourth quarter displayed mild downward pressure influenced by improved import availability and steady domestic consumption. Pharmaceutical producers continued routine procurement, yet refrained from significant stock accumulation. Enhanced import flows from major global suppliers increased competition within local markets, encouraging sellers to offer competitive terms. Currency stability mitigated sharp pricing volatility, providing relative predictability in transaction negotiations.

Q3 2025:

Latin America showed a mixed pricing trend for sulfanilamide during Q3 2025. Brazil, as a key market, saw a slight price increase due to rising pharmaceutical demand. However, other countries in the region, faced price stagnation due to subdued market growth and difficulties in accessing raw materials. Logistics and supply chain inefficiencies in some South American countries continued to put pressure on pricing, particularly in more remote regions. Brazil's strong pharmaceutical market offset regional price challenges, contributing to an overall moderate upward movement in the region.

Q2 2025:

In Latin America, sulfanilamide prices reflected stability with a slight downward bias due to subdued demand from the pharmaceutical and veterinary drug sectors. Import dependency kept the market closely tied to global trade flows, while steady raw material costs prevented major volatility. Buyers maintained conservative purchasing strategies, focusing on immediate needs rather than long-term stocking. Overall, balanced supply conditions, adequate inventories, and cautious market activity contributed to a relatively calm pricing environment, with little room for upward momentum.

This comprehensive review can be extended to include specific countries within the region.

Sulfanilamide Pricing Report, Market Analysis, and News

IMARC's latest publication, “Sulfanilamide Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition,” presents a detailed examination of the sulfanilamide market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of sulfanilamide at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed sulfanilamide prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting sulfanilamide pricing, such as the dynamics of supply and demand, geopolitical influences, and sector specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.

Sulfanilamide Industry Analysis

The global sulfanilamide market size reached USD 41.18 Million in 2025. By 2034, IMARC Group expects the market to reach USD 57.55 Million, at a projected CAGR of 3.79% during 2026-2034. The market is primarily driven by the rising demand in the pharmaceutical and agrochemical sectors and the development of new applications and advancements in pharmaceutical formulations.

Latest News and Developments:

• July 2025: A recent study focused on synthesizing sulfanilamide derivatives to evaluate their anti-cancer potential. Ten derivatives were synthesized using a reflux condensation method. Among them, compound 5d exhibited the highest antioxidant activity and significant inhibition against carbonic anhydrase II (CA-II).

Product Description

Sulfanilamide is an organic sulfonamide compound derived from aniline and sulfonamide chemistry. It is commonly represented as a crystalline solid with functional amino and sulfonamide groups, which give it value in pharmaceutical and chemical synthesis. The compound is known for its role as a base structure in sulfonamide drugs and related intermediates. It has moderate stability under standard storage conditions and is used where controlled reactivity, purity, and consistent composition are required. Sulfanilamide is applied in pharmaceutical intermediates, antimicrobial research, dye manufacturing, specialty chemicals, and laboratory synthesis. Its industrial value comes from its ability to support further chemical modification in regulated production chains.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of sulfanilamide pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting sulfanilamide price volatility, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights, ensuring they remain at the forefront of the sulfanilamide industry.